UniProt ID | MBOA7_HUMAN | |
---|---|---|
UniProt AC | Q96N66 | |
Protein Name | Lysophospholipid acyltransferase 7 {ECO:0000305} | |
Gene Name | MBOAT7 {ECO:0000312|HGNC:HGNC:15505} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 472 | |
Subcellular Localization |
Membrane Multi-pass membrane protein . |
|
Protein Description | Acyltransferase which contributes to the regulation of free arachidonic acid (AA) in the cell through the remodeling of phospholipids. Mediates the conversion of lysophosphatidylinositol (1-acylglycerophosphatidylinositol or LPI) into phosphatidylinositol (1,2-diacyl-sn-glycero-3-phosphoinositol or PI) (LPIAT activity). Prefers arachidonoyl-CoA as the acyl donor. Lysophospholipid acyltransferases (LPLATs) catalyze the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle. Required for cortical lamination during brain development (By similarity).. | |
Protein Sequence | MSPEEWTYLVVLLISIPIGFLFKKAGPGLKRWGAAAVGLGLTLFTCGPHTLHSLVTILGTWALIQAQPCSCHALALAWTFSYLLFFRALSLLGLPTPTPFTNAVQLLLTLKLVSLASEVQDLHLAQRKEMASGFSKGPTLGLLPDVPSLMETLSYSYCYVGIMTGPFFRYRTYLDWLEQPFPGAVPSLRPLLRRAWPAPLFGLLFLLSSHLFPLEAVREDAFYARPLPARLFYMIPVFFAFRMRFYVAWIAAECGCIAAGFGAYPVAAKARAGGGPTLQCPPPSSPEKAASLEYDYETIRNIDCYSTDFCVRVRDGMRYWNMTVQWWLAQYIYKSAPARSYVLRSAWTMLLSAYWHGLHPGYYLSFLTIPLCLAAEGRLESALRGRLSPGGQKAWDWVHWFLKMRAYDYMCMGFVLLSLADTLRYWASIYFCIHFLALAALGLGLALGGGSPSRRKAASQPTSLAPEKLREE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSPEEWTYL ------CCHHHHHHH | 40.81 | 24043423 | |
7 | Phosphorylation | -MSPEEWTYLVVLLI -CCHHHHHHHHHHHH | 15.40 | 24043423 | |
8 | Phosphorylation | MSPEEWTYLVVLLIS CCHHHHHHHHHHHHH | 9.89 | 24043423 | |
15 | Phosphorylation | YLVVLLISIPIGFLF HHHHHHHHCHHHHHH | 23.45 | 24043423 | |
55 (in isoform 2) | Ubiquitination | - | 3.33 | 21890473 | |
55 | Ubiquitination | PHTLHSLVTILGTWA HHHHHHHHHHHHHHH | 3.33 | 23000965 | |
114 | Phosphorylation | LLTLKLVSLASEVQD HHHHHHHHHHHHHHH | 28.75 | 20068231 | |
117 | Phosphorylation | LKLVSLASEVQDLHL HHHHHHHHHHHHHHH | 43.52 | 20068231 | |
128 (in isoform 3) | Ubiquitination | - | 39.50 | 21890473 | |
128 (in isoform 1) | Ubiquitination | - | 39.50 | 21890473 | |
128 | Ubiquitination | DLHLAQRKEMASGFS HHHHHHHHHHHHCCC | 39.50 | 23000965 | |
172 | Phosphorylation | GPFFRYRTYLDWLEQ CCCCCCHHHHHHHHC | 21.36 | 24719451 | |
173 | Phosphorylation | PFFRYRTYLDWLEQP CCCCCHHHHHHHHCC | 8.15 | 24719451 | |
187 | Phosphorylation | PFPGAVPSLRPLLRR CCCCCCCCHHHHHHH | 30.34 | 24719451 | |
212 | Phosphorylation | FLLSSHLFPLEAVRE HHHHHCCCCHHHHHC | 5.63 | 32142685 | |
215 | Ubiquitination | SSHLFPLEAVREDAF HHCCCCHHHHHCCCC | 45.41 | 21963094 | |
277 | Phosphorylation | ARAGGGPTLQCPPPS HHCCCCCCCCCCCCC | 32.51 | 23403867 | |
284 | Phosphorylation | TLQCPPPSSPEKAAS CCCCCCCCCHHHHHH | 65.38 | 23401153 | |
285 | Phosphorylation | LQCPPPSSPEKAASL CCCCCCCCHHHHHHC | 42.74 | 29255136 | |
288 | Acetylation | PPPSSPEKAASLEYD CCCCCHHHHHHCCCC | 53.27 | 26051181 | |
288 | Ubiquitination | PPPSSPEKAASLEYD CCCCCHHHHHHCCCC | 53.27 | 21963094 | |
291 | Phosphorylation | SSPEKAASLEYDYET CCHHHHHHCCCCHHH | 26.96 | 26552605 | |
294 | Phosphorylation | EKAASLEYDYETIRN HHHHHCCCCHHHHCC | 29.17 | 30576142 | |
296 | Phosphorylation | AASLEYDYETIRNID HHHCCCCHHHHCCCE | 17.67 | 26552605 | |
298 | Phosphorylation | SLEYDYETIRNIDCY HCCCCHHHHCCCEEE | 21.00 | 26552605 | |
321 | N-linked_Glycosylation | RDGMRYWNMTVQWWL CCCCCHHHHHHHHHH | 13.81 | UniProtKB CARBOHYD | |
383 | Ubiquitination | EGRLESALRGRLSPG CCCHHHHHCCCCCCC | 9.21 | 33845483 | |
395 (in isoform 2) | Ubiquitination | - | 13.66 | 21890473 | |
395 | Ubiquitination | SPGGQKAWDWVHWFL CCCCHHHHHHHHHHH | 13.66 | 27667366 | |
456 | Ubiquitination | GGSPSRRKAASQPTS CCCHHHHHHHCCCCC | 47.39 | 27667366 | |
459 | Phosphorylation | PSRRKAASQPTSLAP HHHHHHHCCCCCCCH | 41.37 | 25159151 | |
462 | Phosphorylation | RKAASQPTSLAPEKL HHHHCCCCCCCHHHH | 28.83 | 23312004 | |
463 | Phosphorylation | KAASQPTSLAPEKLR HHHCCCCCCCHHHHH | 29.26 | 27251275 | |
468 | Ubiquitination | PTSLAPEKLREE--- CCCCCHHHHHCC--- | 52.35 | 27667366 | |
468 | 2-Hydroxyisobutyrylation | PTSLAPEKLREE--- CCCCCHHHHHCC--- | 52.35 | - | |
468 (in isoform 1) | Ubiquitination | - | 52.35 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MBOA7_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MBOA7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MBOA7_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SPTSA_HUMAN | SPTSSA | physical | 23510452 | |
STOM_HUMAN | STOM | physical | 27173435 | |
ACAP2_HUMAN | ACAP2 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...